Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape. The current Hepatitis C treatment landscape consists of a combination of pegylated interferon, ribavirin and, in patients infected with genotype 1 hepatitis C, one of two direct-acting antiviral agents (DAAs).

For further details visit:

More Details

Total Views:8
Reference Id:#580989
Phone Number:09987295242
Website URL:Click To Visit
Current Rating: /5 0 Vote
Copyright © 2018 |   All Rights Reserved | |   24x7 support |   Email us : info[at]